TAPI, a leading global supplier of APIs, provides over 350 products and customized CDMO solutions for every stage of development.
01 1TEVA PHARMACEUTICAL INDUSTRIES LTD Tel Aviv - Jaffa IL
02 1EXCELLA GMBH & CO. KG Feucht DE
01 1Deferoxamine mesilate, Produced by a synthetic process
02 1Deferoxamine mesilate, Produced by fermentation
01 1Germany
02 1Israel
01 2Valid
TAPI, a leading global supplier of APIs, provides over 350 products and customized CDMO solutions for every stage of development.
TAPI, a leading global supplier of APIs, provides over 350 products and customized CDMO solutions for every stage of development.
Deferoxamine Mesilate, Produced By Fermentation
Certificate Number : R1-CEP 2000-160 - Rev 04
Status : Valid
Issue Date : 2022-06-17
Type : Chemical
Substance Number : 896
Deferoxamine Mesilate, Produced By A Synthetic P...
Certificate Number : CEP 2009-401 - Rev 05
Status : Valid
Issue Date : 2024-10-25
Type : Chemical
Substance Number : 896
A Deferoxamine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Deferoxamine, including repackagers and relabelers. The FDA regulates Deferoxamine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Deferoxamine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Deferoxamine manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Deferoxamine supplier is an individual or a company that provides Deferoxamine active pharmaceutical ingredient (API) or Deferoxamine finished formulations upon request. The Deferoxamine suppliers may include Deferoxamine API manufacturers, exporters, distributors and traders.
click here to find a list of Deferoxamine suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Deferoxamine CEP of the European Pharmacopoeia monograph is often referred to as a Deferoxamine Certificate of Suitability (COS). The purpose of a Deferoxamine CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Deferoxamine EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Deferoxamine to their clients by showing that a Deferoxamine CEP has been issued for it. The manufacturer submits a Deferoxamine CEP (COS) as part of the market authorization procedure, and it takes on the role of a Deferoxamine CEP holder for the record. Additionally, the data presented in the Deferoxamine CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Deferoxamine DMF.
A Deferoxamine CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Deferoxamine CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Deferoxamine suppliers with CEP (COS) on PharmaCompass.
We have 2 companies offering Deferoxamine
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?